Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Houttuynia eye drop spray for dry eye with meibomian gland dysfunction
ChiCTR1800018611Phase 4Not yet recruiting
- Sponsor
- Xiamen Eye Center of Xiamen University
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Houttuynia cordata extract in dry eye syndrome (DED) and meibomian gland dysfunction (MGD) (2 arms), sponsored by Xiamen Eye Center of Xiamen University. Primary endpoints: Total eye symptom score, Single symptom scores and 11 more. Planned start Oct 2018; status: not yet recruiting.
02
Drugs
Houttuynia cordata extract
03
Conditions
dry eye syndrome (DED)meibomian gland dysfunction (MGD)
Beyond the preview
Go deeper on ChiCTR1800018611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018611.